Protocol BVS857X2201: "Multiple Ascending, Sequential, Placebo-controlled, Doubleblind Study to Assess Safety, Tolerability and Efficacy of BVS857 in Severe Burn Patients"

  • Herndon, David, (PI)

Project: Other project

StatusFinished
Effective start/end date1/30/1412/31/16

Funding

  • Novartis Pharmaceuticals Corporation: $33,808.00